Institute of Biomedical Research of Salamanca (IBSAL).
Department of Physiology and Pharmacology, University of Salamanca (USAL), Salamanca, Spain.
Toxicol Sci. 2020 May 1;175(1):75-86. doi: 10.1093/toxsci/kfaa029.
Neutrophil gelatinase-associated lipocalin (NGAL) is a secreted low-molecular weight iron-siderophore-binding protein. NGAL overexpression in injured tubular epithelia partly explains its utility as a sensitive and early urinary biomarker of acute kidney injury (AKI). Herein, we extend mechanistic insights into the source and kinetics of urinary NGAL excretion in experimental AKI. Three models of experimental AKI were undertaken in adult male Wistar rats; renal ischemia-reperfusion injury (IRI) and gentamicin (G) and cisplatin (Cisp) nephrotoxicity. Alongside standard histological and biochemical assessment of AKI, urinary NGAL excretion rate, plasma NGAL concentration, and renal NGAL mRNA/protein expression were assessed. In situ renal perfusion studies were undertaken to discriminate direct shedding of NGAL to the urine from addition of NGAL to the urine secondary to alterations in the tubular handling of glomerular filtrate-derived protein. Renal NGAL expression and urinary excretion increased in experimental AKI. In acute studies in both the IRI and G models, direct renal perfusion with Kreb's buffer eliminated urinary NGAL excretion. Addition of exogenous NGAL to the Kreb's buffer circuit, reestablishment of perfusion with systemic blood or reperfusion with renal vein effluent restored high levels of urinary NGAL excretion. Urinary NGAL excretion in AKI arises in large proportion from reduced reabsorption from the glomerular filtrate. Hence, subclinical cellular dysfunction could increase urinary NGAL, particularly in concert with elevations in circulating prerenal NGAL and/or pharmacological inhibition of tubular reabsorption. More granular interpretation of urinary NGAL measurements could optimize the scope of its clinical utility as a biomarker of AKI.
中性粒细胞明胶酶相关脂质运载蛋白(NGAL)是一种分泌的低分子量铁载体结合蛋白。受损肾小管上皮细胞中 NGAL 的过度表达部分解释了其作为急性肾损伤(AKI)敏感和早期尿生物标志物的用途。在此,我们对实验性 AKI 中尿 NGAL 排泄的来源和动力学的机制有了更深入的了解。在成年雄性 Wistar 大鼠中进行了三种实验性 AKI 模型;肾缺血再灌注损伤(IRI)和庆大霉素(G)和顺铂(Cisp)肾毒性。除了 AKI 的标准组织学和生化评估外,还评估了尿 NGAL 排泄率、血浆 NGAL 浓度和肾 NGAL mRNA/蛋白表达。进行了原位肾灌注研究,以区分 NGAL 直接排入尿液与由于肾小球滤过物衍生蛋白的肾小管处理改变而向尿液中添加 NGAL。在实验性 AKI 中,肾 NGAL 表达和尿排泄增加。在 IRI 和 G 模型的急性研究中,用 Krebs 缓冲液直接肾灌注消除了尿 NGAL 排泄。向 Krebs 缓冲液回路中添加外源性 NGAL、用全身血液重新建立灌注或用肾静脉流出物再灌注可恢复高水平的尿 NGAL 排泄。AKI 中的尿 NGAL 排泄在很大程度上来自于肾小球滤过物的减少重吸收。因此,亚临床细胞功能障碍可增加尿 NGAL,特别是与循环前肾 NGAL 升高和/或肾小管重吸收的药理学抑制同时发生时。更细致的尿 NGAL 测量解释可以优化其作为 AKI 生物标志物的临床应用范围。